Clinical Trial

Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized, multicenter, sham-controlled clinical trial designed to evaluate the efficacy and safety of acupuncture for patients with refractory rosacea. A total of 104 participants will be enrolled and randomly assigned in a 1:1 ratio to the acupuncture group or the sham acupuncture group (52 participants in each group, regardless of sex). The primary aim is to determine whether acupuncture can effectively alleviate facial erythema and flushing episodes compared with sham stimulation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2026-01-28
Trial Details
NCT Number NCT07296497
Lead Sponsor Xiangya Hospital of Central South University
Conditions Rosacea
Enrollment 104 participants
Start Date 2025-12-24
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-30